The evolution of cancer supportive care
Immunotherapy in second-line treatment of non-small cell lung cancer
Toxicities of immunotherapy and patient expectations in lung cancer
The APHINITY debate: should we change our treatment of breast cancer?
Characterizing a phenomenon in GBM patients who do not respond well to immunotherapy